The deal tees up a pain treatment market rivalry with Vertex Pharmaceuticals as the industry starts to move away from opioids ...

Hospitals and health systems across the country continue to face anesthesiologist shortages, with little relief in sight. Research suggests the United States could see a shortfall of 8,450 ...

Analysts have recently evaluated Gevo and provided 12-month price targets. The average target is $10.79, accompanied by a ...

US biotech Syndeio Biosciences has launched with over $90 million in funding and a pipeline of synapse-targeting ...

Nonprofit board fellows programs can be mutually beneficial to students, business schools, and partner organizations.

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study ...

The Legal Intelligencer will honor attorneys and legal professionals at an awards ceremony in June. What is one change you’d ...

Transaction will augment Lilly's efforts to advance non-opioid medicines for pain management INDIANAPOLIS, May 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: ...

Eight RSK Group businesses have been appointed to a major UK carbon capture and storage (CCS) project by United Living Energy ...

Artificial intelligence is transforming. Earlier models could only understand a paragraph, but today’s leading systems can ...

Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the "Company” or "Appili”), a biopharmaceutical company focused on drug ...

Salesforce has finally completed its $8bn deal to purchase Informatica as it looks to take the next step forward on its AI ...